Prospeo
Hero Section BackgroundHero Section Background
IMMUSE Therapeutics

IMMUSE Therapeutics Revenue

Research ServicesFlag of KR7F, 30, Korea, Republic of1-10 Employees

$

IMMUSE Therapeutics revenue & valuation

Annual revenue$171,110
Revenue per employee$86,000
Estimated valuation?$547,552
Total funding$4,200,000

Key Contact at IMMUSE Therapeutics

Flag of US

Jaehun Chung

CEO / Founder

Company overview

Headquarters7F, 30, Gasan digital 2-ro, Geumcheon-gu, Seoul, 08592, KR
Phone number+82264992440
Website
NAICS5417
Keywords
Biotech, Platform, Therapeutics, Clinical Studies, Immune
Founded2021
Employees1-10

About IMMUSE Therapeutics

We hope to be a biotech company specializing in the development of innovative immune-based therapeutics through successful clinical studies and market launching of platform.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

IMMUSE Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore IMMUSE Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date
Round
Amount
Link to Article
2022-08-013$4,200,000

Funding Insights

$4,200,000

Total funding amount

$4,200,000

Most recent funding amount

1

Number of funding rounds

Frequently asked questions

IMMUSE Therapeutics is located in 7F, 30, KR.
You can reach IMMUSE Therapeutics at +82264992440.
IMMUSE Therapeutics generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
IMMUSE Therapeutics has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
IMMUSE Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.
IMMUSE Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
IMMUSE Therapeutics has raised a total of $4,200,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

4.8

40,000 users

top 50
high performer
most used
tier 1 accuracy

Build leads list with verified emails & mobiles